ClinicalTrials.Veeva

Menu

Analysis of the Loss of Muscle Force, Muscle Power and Motor Control Degradation to Predict the Risk of Falls in Patients With Knee Osteoarthritis (PowerAGING)

I

Istituto Ortopedico Rizzoli

Status

Enrolling

Conditions

Knee Osteoarthritis (Knee OA)
Falls Prevention

Treatments

Other: Muscle power assessment
Diagnostic Test: Magnetic Resonance Imaging
Other: Muscle force assessment
Other: Home-based mobility monitoring
Other: Gait assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT06611618
CE-AVEC 204/2024/Sper/IOR

Details and patient eligibility

About

The twofold goal of this study is to understand the link between muscle power, muscle strength, and muscle control degradation with the risk of falling, and to develop a framework for the comprehensive and quantitative assessment of muscle power (and strength) in an elderly population of patients with knee osteoarthritis, who are at higher risk of falling. The main question it aims to answer is:

● Are muscle power and motor control degradation better predictors of falls than muscle strength in the aging population?

Participants will undergo:

  • Muscle force assessment on a dynamometer
  • Muscle power assessment on a dynamometer and on isntrumented stairs
  • Home-based mobility monitoring
  • Full lower limb MRI acquisition
  • Gait assessment

Full description

Falls are a critical yet common event among the elderly, with huge societal and economic impact (reduced quality of life and high costs for the healthcare system). Experimental measures to quantify the residual muscle strength and power may provide useful information to predict the risk of falls in the elderly. Isometric and isokinetic muscle contractions, performed on a dynamometer or during functional tasks can be collected, together with electromyography (to assess muscle activity) and imaging data (to quantify and characterize muscular tissue).

Such data can be collected at different time points to monitor subjects over time, and to inform virtual representation of the human musculoskeletal system (digital twins) to identify possible motor control deficits. Moreover, this same information can be used to better characterize/assess elder individuals at risk of falling (e.g., subjects with knee osteoarthritis), to prevent future falls.

All subjects enrolled in the PowerAGING study will be followed up for 24 months (5 visits in total: M0, M6, M12, M18 and M24 follow-up). At each visit, a series of experimental tests to quantify muscle power and muscle force, as well as a home-based mobility assessment (via single inertial sensor worn for 5 consecutive days), will be performed. In addition, only at start and end, the subjects will undergo a full lower limb MRI and a gait assessment.

Enrollment

50 estimated patients

Sex

All

Ages

65 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 65 and 80 years
  • Kellgren score II e III
  • No history of falls in the last 12 months

Exclusion criteria

  • Any musculoskeletal, neurological, rheumatic or tumoral diseases
  • Dementia
  • Diabetes
  • Inguinal or abdominal hernia
  • Severe Hypertension (Level 3)
  • Severe Cardio-pulmonary insufficiency
  • Diagnosis of Osteonecrosis in the lower limb joints
  • Pathologies or physical conditions incompatible with the use of magnetic resonance imaging and electrostimulation (i.e., active and passive implanted biomedical devices, epilepsy, severe venous insufficiency in the lower limbs)
  • Previous interventions or traumas to the joints of the lower limb

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Knee Osteoarthritis
Experimental group
Description:
Elderly patients with knee osteoarthritis, without a history of falls (in the 12 months prior to enrollment). All subjects will be followed up for 24 months, every 6 months. Muscle force and power assessments, plus a home-based mobility monitoring, will be performed at all visits. Full lower limb MRI and a gait assessment will be performed at first and last visit.
Treatment:
Other: Gait assessment
Other: Home-based mobility monitoring
Other: Muscle force assessment
Diagnostic Test: Magnetic Resonance Imaging
Other: Muscle power assessment

Trial contacts and locations

1

Loading...

Central trial contact

Lisa Berti, Professor; Massimiliano Baleani, Engineer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems